Clinical Trial: Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07487701) titled 'Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study' on March 17.

Brief Summary: Preventive pharmacologic therapies for migraine aim to reduce attack frequency and duration and improve quality of life; however, their use, overall benefit and adherence are often limited, especially among patients with chronic migraine. Remote electrical neuromodulation (REN) is a non-invasive FDA-cleared wearable device for acute and/or preventive migraine treatment. This study evaluated the real-world efficacy and patient-reported outcomes of preventive REN use over 3 months in chronic migraine...